New York State Challenges the White House's Stance on Legal Cannabis
A New York family will go to court Wednesday to challenge the federal government, arguing that cannabis shouldn't be a Schedule 1 drug. Amanda Ostrowitz, co-founder and CEO of CannaRegs, says the case might not change the laws
For full interview [click here](https://cheddar.com/videos/how-cannaregs-is-capitalizing-on-cannabis).
Arjan Stephens, President of Nature's Path, discusses the company's origin, how it has evolved today and the interesting product that came from his wedding!
Small business reporter, Gene Marks, joins Cheddar to give analysis on how small businesses are tackling incoming tariffs and how it will affect the consumer.
Babylist CEO Natalie Gordon joins Cheddar to discuss how the website is helping new parents, how to make a registry and how secondhand options are available.
Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection.
ReturnPro CEO Sender Shamiss to discuss how his company is changing the way we make returns and how Trump's tariffs are affecting the return business. Watch!
